Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Microbiome Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Microbiome Drugsmarket, defines the market attractiveness level of Microbiome Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Microbiome Drugs industry, describes the types of Microbiome Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Microbiome Drugs market and the development prospects and opportunities of Microbiome Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Microbiome Drugs market in Chapter 13.
By Player:
MicroBiome Therapeutics
Pfizer
Enterome Bioscience
Ritter Pharmaceuticals
Second Genome
MaaT Pharma
Seres Therapeutics
OpenBiome
Rebiotix
By Type:
Probiotics
Prebiotics
Small Molecules
Biological Drugs
Other
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Microbiome Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Microbiome Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Microbiome Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Microbiome Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Microbiome Drugs Market Analysis and Outlook to 2022
-
7.1 Global Microbiome Drugs Consumption (2017-2022)
-
7.2 United States Microbiome Drugs Consumption (2017-2022)
-
7.3 Europe Microbiome Drugs Consumption (2017-2022)
-
7.4 China Microbiome Drugs Consumption (2017-2022)
-
7.5 Japan Microbiome Drugs Consumption (2017-2022)
-
7.6 India Microbiome Drugs Consumption (2017-2022)
-
7.7 South Korea Microbiome Drugs Consumption (2017-2022)
8 Region and Country-wise Microbiome Drugs Market Analysis and Outlook to 2028
-
8.1 Global Microbiome Drugs Consumption Forecast (2022-2028)
-
8.2 United States Microbiome Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Microbiome Drugs Consumption Forecast (2022-2028)
-
8.4 China Microbiome Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Microbiome Drugs Consumption Forecast (2022-2028)
-
8.6 India Microbiome Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Microbiome Drugs Consumption Forecast (2022-2028)
9 Global Microbiome Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Microbiome Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Probiotics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Prebiotics Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Small Molecules Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Biological Drugs Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Microbiome Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Microbiome Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Microbiome Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Probiotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Prebiotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Small Molecules Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Biological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Microbiome Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Microbiome Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Microbiome Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Microbiome Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Microbiome Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Microbiome Drugs Market Competitive Analysis
-
14.1 MicroBiome Therapeutics
-
14.1.1 MicroBiome Therapeutics Company Details
-
14.1.2 MicroBiome Therapeutics Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 MicroBiome Therapeutics Microbiome Drugs Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Microbiome Drugs Product and Service
-
14.3 Enterome Bioscience
-
14.3.1 Enterome Bioscience Company Details
-
14.3.2 Enterome Bioscience Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Enterome Bioscience Microbiome Drugs Product and Service
-
14.4 Ritter Pharmaceuticals
-
14.4.1 Ritter Pharmaceuticals Company Details
-
14.4.2 Ritter Pharmaceuticals Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Ritter Pharmaceuticals Microbiome Drugs Product and Service
-
14.5 Second Genome
-
14.5.1 Second Genome Company Details
-
14.5.2 Second Genome Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Second Genome Microbiome Drugs Product and Service
-
14.6 MaaT Pharma
-
14.6.1 MaaT Pharma Company Details
-
14.6.2 MaaT Pharma Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 MaaT Pharma Microbiome Drugs Product and Service
-
14.7 Seres Therapeutics
-
14.7.1 Seres Therapeutics Company Details
-
14.7.2 Seres Therapeutics Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Seres Therapeutics Microbiome Drugs Product and Service
-
14.8 OpenBiome
-
14.8.1 OpenBiome Company Details
-
14.8.2 OpenBiome Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 OpenBiome Microbiome Drugs Product and Service
-
14.9 Rebiotix
-
14.9.1 Rebiotix Company Details
-
14.9.2 Rebiotix Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Rebiotix Microbiome Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Microbiome Drugs
-
Figure Microbiome Drugs Picture
-
Table Global Microbiome Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Microbiome Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Microbiome Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Microbiome Drugs Consumption by Country (2017-2022)
-
Figure United States Microbiome Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Microbiome Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Microbiome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Microbiome Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Microbiome Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Microbiome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Microbiome Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Microbiome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Microbiome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Microbiome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Microbiome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Microbiome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Microbiome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Probiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Prebiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Small Molecules Consumption and Growth Rate (2017-2022)
-
Figure Global Biological Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Probiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prebiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Small Molecules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Microbiome Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Microbiome Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table MicroBiome Therapeutics (Foundation Year, Company Profile and etc.)
-
Table MicroBiome Therapeutics Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table MicroBiome Therapeutics Microbiome Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Microbiome Drugs Product and Service
-
Table Enterome Bioscience (Foundation Year, Company Profile and etc.)
-
Table Enterome Bioscience Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enterome Bioscience Microbiome Drugs Product and Service
-
Table Ritter Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Ritter Pharmaceuticals Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ritter Pharmaceuticals Microbiome Drugs Product and Service
-
Table Second Genome (Foundation Year, Company Profile and etc.)
-
Table Second Genome Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Second Genome Microbiome Drugs Product and Service
-
Table MaaT Pharma (Foundation Year, Company Profile and etc.)
-
Table MaaT Pharma Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table MaaT Pharma Microbiome Drugs Product and Service
-
Table Seres Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Seres Therapeutics Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seres Therapeutics Microbiome Drugs Product and Service
-
Table OpenBiome (Foundation Year, Company Profile and etc.)
-
Table OpenBiome Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table OpenBiome Microbiome Drugs Product and Service
-
Table Rebiotix (Foundation Year, Company Profile and etc.)
-
Table Rebiotix Microbiome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rebiotix Microbiome Drugs Product and Service
-
